Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review-Reference-Cited by-同舟云学术

Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review

Published:2014-01-03 Issue:1 Volume:12 Page:19-32
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Caires de Souza Ana Luísa,Acurcio Francisco de Assis,Guerra Júnior Augusto Afonso,Rezende Macedo do Nascimento Renata Cristina,Godman Brian,Diniz Leonardo Maurício

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40258-013-0073-6.pdf

Reference58 articles.

1. Godman B, Bennie M, Baumgärtel C, Sović Brkičić L, et al. Essential to increase the use of generics in Europe to maintain comprehensive healthcare? Farmecon Health Econ Ther Pathw. 2012;13(Suppl 3):5–20.

2. Godman B, Abuelkhair M, Vitry A, Abdu S, et al. Payers endorse generics to enhance prescribing efficiency; impact and future implications, a case history approach. GABI. 2012;1(2):69–83.

3. Wettermark B, Godman B, Andersson K, Gustafsson LL, Haycox A, Bertele V. Recent national and regional drug reforms in Sweden—implications for pharmaceutical companies in Europe. Pharmacoeconomics. 2008;26:537–50.

4. Coma A, Zara C, Godman B, Augusta A, Diogenes E, Wettermark B, Haycox A. Policies to enhance the efficiency of prescribing in the Spanish Catalan Region: impact and future direction. Expert Rev Pharmacoecon Outcomes Res. 2009;9:569–81.

5. Godman B, Wettermark B, Hoffman M, Andersson K, Haycox A, Gustafsson LL. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden; global relevance. Expert Rev Pharmacoecon Outcomes Res. 2009;9:65–83.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study;Expert Review of Pharmacoeconomics & Outcomes Research;2024-07-26

2. A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications;Clinical Diabetes;2022-07-01

3. Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2022-05-25

4. Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions;Expert Review of Pharmacoeconomics & Outcomes Research;2022-04-04

5. Enhancing Choices Regarding the Administration of Insulin Among Patients With Diabetes Requiring Insulin Across Countries and Implications for Future Care;Frontiers in Pharmacology;2022-01-14